Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells

Cited by (276)

Items 201–276 of 276

  1. TERT Amplification a Risk Stratification Marker in Papillary Thyroid Carcinoma, Significantly Correlated with Tumor Recurrence and Survival
    Sara Gil‐Bernabé, Noa Feás-Rodríguez, Enrique Pérez-Riesgo, Miriam Corraliza-Gómez, J. Fra, Ginesa García‐Rostán · 2025 · Endocrine Pathology
  2. Human telomerase reverse transcriptase (hTERT) synergistic with Sp1 upregulate Gli1 expression and increase gastric cancer invasion and metastasis
    Lingyi Wu, Sumin Wang, Bo Tang, Li Tang, Yuanyuan Lei, Yaojiang Liu, Min Yang, Guodong Yang, Dan Zhang, En Liu · 2021 · Journal of Molecular Histology
  3. Extra-telomeric functions of telomerase in the pathogenesis of Epstein-Barr virus-driven B-cell malignancies and potential therapeutic implications
    Silvia Giunco, Maria Raffaella Petrara, Manuela Zangrossi, Andrea Celeghin, Anita De Rossi · 2018 · Infectious Agents and Cancer
  4. TGF‐β‐mediated regulation of plasminogen activators is human telomerase reverse transcriptase dependent in cancer cells
    Rishi Kumar Jaiswal, Pramod Kumar Yadava · 2019 · BioFactors
  5. Helicobacter pylori Induces a Novel NF-kB/LIN28A/let-7a/hTERT Axis to Promote Gastric Carcinogenesis
    Shen Li, Jiping Zeng, Lin Ma, Shuyan Li, Chunyan Chen, Jihui Jia, Xiuming Liang · 2020 · Molecular Cancer Research
  6. Epithelial-mesenchymal transition in gastroenterological cancer
    Hideo Baba, Hirohisa Okabe, Kosuke Mima, Seiya Saito, Hiromitsu Hayashi, Katsunori Imai, Hidetoshi Nitta, Daisuke Hashimoto, Akira Chikamoto, Takatoshi Ishiko et al. · 2015 · Journal of Cancer Metastasis and Treatment
  7. Genetic Variants Associated with Thyroid Cancer Risk: Comprehensive Research Synopsis, Meta-Analysis, and Cumulative Epidemiological Evidence
    Ran Ran, Gang Tu, Hui Li, Hao Wang, Exian Mou, Caiyang Liu · 2021 · Journal of Oncology
  8. Telomerase activity: An attractive target for cancer therapeutics
    Lucia Picariello · 2014 · World Journal of Pharmacology
  9. Fundamental insights into autosomal dominant polycystic kidney disease from human-based cell models
    Caroline Weydert, Jean-Paul Decuypere, Humbert DE SMEDT, Peter Janssens, Rudi Vennekens, Djalila Mekahli · 2018 · Pediatric Nephrology
  10. The TERT copy number gain is sensitive to telomerase inhibitors in human melanoma
    Jinyu Yu, Jiayi Yu, Xiaowen Wu, Qian Guo, Ting Yin, Zhiyuan Cheng, Jie Dai, Yan Kong, Jun Guo · 2020 · Clinical Science
  11. Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer
    Tomoya Kato, Mikihito Nakamori, Shuichi Matsumura, Masaki Nakamura, Toshiyasu Ojima, Hiroshi Fukuhara, Yasushi Ino, Tomoki Todo, Hiroki Yamaue · 2021 · Oncology Letters · Retracted
  12. Dyskerin and telomerase RNA component are sex-differentially associated with outcomes and Sunitinib response in patients with clear cell renal cell carcinoma
    Huiyang Yuan, Xin Qin, Qingya Yang, Li Liu, Zhiqing Fang, Yidong Fan, Dawei Xu · 2023 · Biology of Sex Differences
  13. Therapeutic cancer vaccination against telomerase: clinical developments in melanoma
    Espen B. Ellingsen, Jens Bjørheim, Gustav Gaudernack · 2023 · Current Opinion in Oncology
  14. Telomerase inhibition decreases esophageal squamous carcinoma cell migration and invasion
    Jiayan Li, Guogang Dong, Jinyun Song, Guolei Tan, Xuping Wu · 2020 · Oncology Letters
  15. Silencing hTERT attenuates cancer stem cell-like characteristics and radioresistance in the radioresistant nasopharyngeal carcinoma cell line CNE-2R
    Kai-Hua Chen, Ling Li, Song Qu, Xin‐Bin Pan, Yongchu Sun, Fangzhu Wan, Binbin Yu, Lei Zhou, Xiaodong Zhu · 2020 · Aging
  16. C-MYC as a key effector of WNT, PI3K/AKT, MAPK, and TGF-β signaling pathways in regulation of epithelial-mesenchymal transition during tumor metastasis
    Meysam Moghbeli · 2026 · Cancer Cell International
  17. HES1 in cancer: a key player in tumorigenesis and its prognostic significance
    Venkataraman Magesh, Ramya Sekar, Abdullah M. Alzahrani, Rajkapoor Balasubramanian, Salaheldin Abdelraouf Abdelsalam, Peramaiyan Rajendran · 2025 · Molecular Genetics and Genomics
  18. [Retracted] Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer
    Tomoya Kato, Mikihito Nakamori, Shuichi Matsumura, Masaki Nakamura, Toshiyasu Ojima, Hiroshi Fukuhara, Yasushi Ino, Tomoki Todo, Hiroki Yamaue · 2021 · Oncology Letters · Retracted
  19. Alveolar epithelial-to-mesenchymal transition in scleroderma interstitial lung disease: Technical challenges, available evidence and therapeutic perspectives
    Enrico De Lorenzis, Christopher W. Wasson, Francesco Del Galdo · 2023 · Journal of Scleroderma and Related Disorders
  20. The combined signatures of telomere and immune cell landscape provide a prognostic and therapeutic biomarker in glioma
    Xu Han, Zihan Yan, Kaiyu Fan, Xueyi Guan, Bohan Hu, Xiang Li, Yunwei Ou, Bing Cui, Lingxuan An, Yaohua Zhang et al. · 2023 · Frontiers in Immunology
  21. The use of transformed IMR90 cell model to identify the potential extra-telomeric effects of hTERT in cell migration and DNA damage response
    Xu Cao, Chiou Mee Kong, Kanchi Madhu Mathi, Yoon Pin Lim, Valère Cacheux-Rataboul, Xueying Wang · 2014 · BMC Biochemistry
  22. Effects of long‐term exposure to MST‐312 on lung cancer cells tumorigenesis: Role of SHH/GLI‐1 axis
    Nícolas Jones Villarinho, Flavia da Cunha Vasconcelos, Luciano Mazzoccoli, Marcela Cristina Robaina, Luciana Santos Pessoa, Pablo Enrique Torres Siqueira, Raquel Ciuvalschi Maia, Diêgo Madureira de Oliveira, Tânia Cristina Leite de Sampaio e Spohr, Giselle Pinto de Faria Lopes · 2022 · Cell Biology International
  23. Centros educativos de calidad
    Ramón Pérez Juste, Gregorio Rodríguez Gómez, Catalina Martínez Mediano · 1994 · Dialnet (Universidad de la Rioja)
  24. Multifunctional molecular hybrid for targeted colorectal cancer cells: Integrating doxorubicin, AS1411 aptamer, and T9/U4 ASO
    Kanpitcha Jiramitmongkon, Pichayanoot Rotkrua, Paisan Khanchaitit, Jiraporn Arunpanichlert, Boonchoy Soontornworajit · 2025 · PLoS ONE
  25. Shedding Light on the Interaction Between Rif1 and Telomeres in Ovarian Cancer
    Paweł Kordowitzki, Szymon Graczyk, Sylvia Mechsner, Jalid Sehouli · 2023 · Aging and Disease
  26. Olovnikov, Telomeres, and Telomerase. Is It Possible to Prolong a Healthy Life?
    Yegor E. Yegorov · 2023 · Biochemistry (Moscow)
  27. Identification and validation of telomerase related lncRNAs signature to predict prognosis and tumor immunotherapy response in bladder cancer
    Xiaoxu Chen, Zheng Qin, Xiao Ming Zhu, Lili Wang, Changying Li, Haitao Wang · 2023 · Scientific Reports
  28. Cross-talk of Three Molecular Subtypes of Telomere Maintenance Defines Clinical Characteristics and Tumor Microenvironment in Gastric Cancer
    Mengpei Yan, Zhijun Zhang, Luyao Wang, Hongxin Huang, Jihuan Wang, Chengjun Zhu, Zheng Li, Zekuan Xu · 2024 · Journal of Cancer
  29. Nano-biomaterials in cancer therapy: Advances in targeting and overcoming cancer stem cell resistance
    Marzieh Dehghani, Behnam Hajipour Verdom, Fatemeh Rahimzadeh, Parviz Abdolmaleki · 2025 · ADMET & DMPK
  30. Telomere Maintenance and Oncogenesis
    Antonio Torres-Montaner · 2025 · International Journal of Molecular Sciences
  31. The telomerase vaccine UV1 combined with ipilimumab and nivolumab versus ipilimumab and nivolumab in advanced melanoma (INITIUM): A randomized open-label phase 2 study
    Paul C. Lorigan, Theresa Michelle Medina, Marta Nyakas, Annemie Rutten, Lynn G. Feun, Charles Lance Cowey, Miranda Payne, Israr Hussain, Timothy Michael Kuzel, Steven J O'Day et al. · 2025 · European Journal of Cancer
  32. Levels of neoangiogenesis factors in pathological tissues of gastric cancer patients
    Oleg Ivanovich Kit, Elena Mikhaylovna Frantsiyants, Irina Viktorovna Kaplieva, Yu. A. Gevorkyan, Natalya Vasilievna Soldatkina, Elena Alekseevna Dzhenkova, Nikolay S. Samoylenko, Y.A. Pogorelova · 2019 · Экспериментальная и клиническая гастроэнтерология
  33. Yes-associated protein 1 as a prognostic biomarker and its correlation with telomerase in various cancers
    Hye-Ran Kim, Choong-Won Seo, Keunje Yoo, Sang Jun Han, Jongwan Kim · 2021 · Osong Public Health and Research Perspectives
  34. TERT gene rearrangement in chordomas and comparison to other TERT-rearranged solid tumors
    Ju‐Yoon Yoon, Wei Hong Jiang, Christopher R. Orr, Chase Rushton, Stacey Gargano, Sharon J. Song, Mitul Modi, Bryan A. Hozack, John A. Abraham, Atrayee Basu Mallick et al. · 2021 · Cancer Genetics
  35. Niche Induces Dedifferentiation
    Puja Sarkar Aditi Kapoor · 2013 · Journal of Bioanalysis & Biomedicine
  36. Introduction to cancer biology
    Mehdi Azizi, Hadi Kokabi, Hassan Dianat‐Moghadam, Mohammad Mehrmohammadi · 2022 · Elsevier eBooks
  37. Zinc Finger E-box binding Homeobox 1 as Prognostic Biomarker and its Correlation with Infiltrating Immune Cells and Telomerase in Lung Cancer
    Hye-Ran Kim, Choong-Won Seo, Jongwan Kim · 2022 · Journal of Experimental & Biomedical Sciences/Biomedical Science Letters
  38. SMAR1 suppresses the cancer stem cell population via hTERT repression in colorectal cancer cells
    Apoorva Parulekar, Arpankumar Choksi, Nandaraj Taye, Totakura V. S. Kumar, Priyanka Firmal, Gopal C. Kundu, Samit Chattopadhyay · 2021 · The International Journal of Biochemistry & Cell Biology
  39. Simultaneous imaging of telomerase activity and protein tyrosine kinase 7 in living cells during epithelial-mesenchymal transformation via a near-infrared light-activatable nanoprobe
    Xiuyan Ren, Xiaopeng Liu, Qi Zhang, Chunguang Yang, Zhang-Run Xu · 2024 · Talanta
  40. Development of 3D Cell-Based Fluorescent Reporter Assay for Screening of Drugs Downregulating Telomerase Reverse Transcriptase
    You Li, Fengli Zhang, Zhen Qin, Shang‐Tian Yang · 2025 · Bioengineering
  41. Identification of TMEM115 as a tumor suppressor gene and clinical prognostic factor that influences TERT expression in pancreatic cancer
    Yu Sakano, Takahito Ohira, Haruka Ooi, Miyu Murata, Takuki Yagyu, Yuji Nakayama, Tomohiko Sakabe, Teruhisa Sakamoto, Yoshihisa Umekita, Yoshiyuki Fujiwara et al. · 2026 · Scientific Reports
  42. Molecular Biology of the Oral Cancer
    Tomonori Sasahira, Hiroki Kuniyasu · 2015 · Springer eBooks
  43. A Novel Liquid Biopsy Strategy to Detect Small Amounts of Cancer Cells Using Cancer-Specific Replication Adenoviruses
    Masahiro Takakura, Emi Takata, Toshiyuki Sasagawa · 2020 · Journal of Clinical Medicine
  44. TGF-β Signaling Pathway and Its Therapeutic Role in Cancer
    Antonisamy William James, Hilal Mohiuddin Bhat, Shahid Yousuf, Masrat Jan, Muneeb U. Rehman, Shahzada Mudasir Rashid · 2025 · Springer eBooks
  45. Identification of telomere maintenance-driven molecular subtypes in hepatocellular carcinoma: implications for prognosis and targeted therapy via KPNA2
    Zhicheng Xu, Hanyu Wang, Haixia Tian, Weijing Wang, Dong Hua · 2025 · Discover Oncology
  46. On the Far Side of Telomeres: The Many Roles of Telomerase in the Acquisition and Retention of Cancer Stemness
    Kerem Teralı, Açelya Yılmazer · 2016 · InTech eBooks
  47. Skin Neuroendocrine Neoplasms
    Sofia Asioli · 2020 · Springer eBooks
  48. Telomerase reverse transcriptase (TERT) : promoter mutation and novel function in human cancer
    Tiantian Liu · 2014 · Figshare
  49. Telomerase mutations and carcinogenesis
    Zhiming Cai, XiaoQiang GUO, WeiRen HUANG · 2015 · Chinese Science Bulletin (Chinese Version)
  50. Telomeres and telomerase and their functional applications in myeloproliferative neoplasms and acute myeloid leukemia
    Jenny Dahlström · 2016 · Figshare
  51. Patients with delusional and bizarre thinking.
    R E Anstett, S R Poole, L Wood · 1984 · PubMed
  52. Interrogating telomerase activity and telomere function through in-flask template evolution
    Margaret Pruitt · 2017 · KU ScholarWorks (The University of Kansas)
  53. Expression and role of BORIS/CTCFL in human cancer stem cells
    Loredana Alberti · 2014 · IRIS
  54. Aging-related neoplasia
    Ana Bela Sarmento‐Ribeiro, Maria Filomena Botelho, Ana Cristina Gonçalves, Joana Barbosa Melo, Mafalda Laranjo, Raquel Alves, Joana Jorge, Ilda Patrícia Ribeiro, Salomé Pires, Ana Margarida Abrantes et al. · 2022 · Elsevier eBooks
  55. Telomerase Reverse Transcriptase in Humans: From Biology to Cancer Immunity
    Magalie Dosset, Andrea Castro, Xian Su, Hannah K. Carter, Maurizio Zanetti · 2022 · Interdisciplinary cancer research
  56. Cross-talk between NF-κB and telomerase in cancer: Implications in therapy
    Shrey Madeka, Ekta Khattar · 2023 · Elsevier eBooks
  57. Data from Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial
    Espen B. Ellingsen, Steven J O'Day, Artur Mezheyeuski, Agnieszka Gromadka, Trevor Clancy, Timothy S. Kristedja, Mohammed M. Milhem, Yousef Zakharia · 2023
  58. Data from Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial
    Espen B. Ellingsen, Steven J O'Day, Artur Mezheyeuski, Agnieszka Gromadka, Trevor Clancy, Timothy S. Kristedja, Mohammed M. Milhem, Yousef Zakharia · 2023
  59. Loss of CDH16 expression is a strong independent predictor for lymph node metastasis in Middle Eastern papillary thyroid cancer
    Abdul K. Siraj, Sandeep Kumar Parvathareddy, Maha M. Al-Rasheed, Padmanaban Annaiyappanaidu, Nabil Siraj, Maximilian Lennartz, Saif S. Al-Sobhi, Fouad Al‐Dayel, Guido Sauter, Khawla Sami Al-Kuraya · 2023 · Scientific Reports
  60. Hippo Signaling Pathway in Cancer Stem Cell
    Wang Shen, Weijian Zhao, Hongting Xu, Xiangqian Xiao · 2023
  61. Olovnikov, telomeres and telomerase. is it possible to prolong a healthy life?
    Y. E. Yegorov · 2023 · Biochemistry (Moscow)
  62. A telomere-related gene panel predicts the prognosis and Immune Status in gastric cancer
    Dai Zhang, Dingli Song, Yiche Li, Fenfen He, Qian Hao, Yujiao Deng, Si Yang, Hui Zhu Wang, Jianghao Chen, Ting Wang · 2024 · Research Square
  63. Using deep learning to decipher the impact of telomerase promoter mutations on the dynamic metastatic morpholome
    Andres J. Nevarez, Anusorn Mudla, Sabrina A. Diaz, Nan Hao · 2024 · PLoS Computational Biology
  64. The phenomenon of the BRAF and TERTp mutational duet in melanoma and other cancers
    Dagmara Rusinek, Aleksandra Pfeifer, Artur Zajkowicz, Karolina Tęcza, Jolanta Pamuła‐Piłat, Anna Malgorzata Czarnecka, Małgorzata Oczko‐Wojciechowska · 2024 · Nowotwory Journal of Oncology
  65. Role of Cancer Stem Cells in Ocular Tumors
    Radhika Manukonda, Geeta Kashyap Vemuganti · 2025 · Advances in Ophthalmology and Optometry
  66. Identification of TMEM115 as a tumor suppressor gene through TERT regulation in pancreatic cancer
    Hiroyuki Kugoh, Yu Sakano, Takahito Ohira, Haruka Ui, Takuki Yagyu, Tomohiko Sakabe, Teruhisa Sakamoto, Yoshihisa Umekita, Yoshiyuki Fujiwara · 2025 · Research Square
  67. Telomerase reverse transcriptase degradation via a rationally designed covalent proteolysis targeting chimera
    Grant B. Frost, Yue Liu, Stephen J. Kron, Karl A. Scheidt · 2025 · Bioorganic & Medicinal Chemistry Letters
  68. Calcifying nested stromal-epithelial tumor of the liver: Report of two cases revealing novel WT1 mutation and distinct epigenetic features
    Andrea Straková Peteříková, Franco Fedeli, Boris Rychlý, Jiří Soukup, Michael Michal, Petr Martínek, Marián Grendár, Elaheh Mosaieby, Nikola Ptáková, Maryna Slisarenko et al. · 2025 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  69. Additional file 1 of Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination
    Ellingsen, Espen Basmo, Gergana Bounova, Iliana Kyriaki Kerzeli, Irantzu Anzar, Donjetë Simnica, Elin Aamdal, Tormod Kyrre Guren, Trevor Clancy, Artur Mezheyeuski, Else Marit Inderberg et al. · 2022 · Figshare
  70. Additional file 1 of Dyskerin and telomerase RNA component are sex-differentially associated with outcomes and Sunitinib response in patients with clear cell renal cell carcinoma
    Yuan, Huiyang, Xin Qin, Yang, Qingya, Liu, Li, Fang, Zhiqing, Fan, Yidong, Dawei Xu · 2024 · Figshare
  71. Régulation des cellules initiatrices de tumeurs dans le cancer colorectal par la Progastrine
    Julie Giraud · 2013 · theses.fr (ABES)
  72. Role of the xenoreceptor PXR (NR1I2) in colon cancer stem cells drug resistance and tumor relapse
    Fatemeh Rajabi · 2015 · theses.fr (ABES)
  73. Maintenance des télomères dans la carcinogenèse hépatique : fonction et transfert vers la clinique
    Massih Ningarhari · 2022 · theses.fr (ABES)
  74. Développement d’immunothérapies contre l’antigène de tumeur universel hTERT basées sur différentes stratégies vaccinales
    Élodie Pliquet · 2015 · theses.fr (ABES)
  75. Genomic characterisation of rare thoracic tumours
    Lise Mangiante · 2021 · theses.fr (ABES)
  76. The impact of chronic exposure to cigarette and waterpipe smoke extracts on telomeres, telomerase, and cancer progression
    Daria Azar, Danya Kabbani, Carole Abdel Karim, Reem Akika, Pamela N. Melki, Mario El Hourani, Rola Salman, Farah J. Nassar, Alan Shihadeh, Akram Ghantous et al. · 2026 · Frontiers in Genetics